Drug induced liver disease: Clinical and pathological patterns in 33 cases;Daño hepático por fármacos: Características clínicas e histológicas en 33 casos

Revista Medica de Chile

Volumn 131, Issue 10, 2003, Pages 1128-1134

  Contreras B, Jorge ^a   Poniachik T, Jaime ^a,b   Planzer D, Marcela ^a   Lazarte C, Raúl ^a   Smok S, Gladys ^b   Oksenberg R, Danny ^a   Madrid S, Ana María ^a   Brahm B, Javier ^a  

^a Departamento de Medicina Familiar   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Drug hypersensitivity; Drug toxicity

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTITHYROID AGENT; BILIRUBIN; CENTRAL STIMULANT AGENT; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DICLOFENAC; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GAMMA GLUTAMYLTRANSFERASE; HALOTHANE; HORMONE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; ISOMETHEPTENE; ISONIAZID; LAMIVUDINE; METHOTREXATE; METHYLDOPA; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROCARBAZINE; PYRAZINAMIDE; RETINOID; RIFAMPICIN; ZIDOVUDINE;

ARTICLE; CHOLESTASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; FREQUENCY ANALYSIS; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER NECROSIS; LIVER TOXICITY; RATING SCALE; ADULT; AGED; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; MIDDLE AGED; TOXIC HEPATITIS;

ADULT; AGED; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED;

EID: 1542442714     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ZIMMERMAN HJ, ISHAK KG. General aspects of drug induced liver disease. Gastroenterol Clin North Am 1995; 248; 24: 739-57.
2. ZIMMERMANN HJ. Drug-induced liver disease. Clinics in Liver Disease 2000; 4: 73-96.
3. MARIA VA, VICTORINO RM. Development and validation of a clinical for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664-9.
4. AITHAL GP, RAWLINS MD, DAY CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33: 949-52.
5. BENICHOU C. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990; 11: 272-6.
6. LEWIS JH. Drug-induced Liver Disease. Med Clin North Am 2000; 84: 1275-311.
7. GILBERT SC, KLINTMALM G, MENTER A, SILVERMAN A. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis: A word of caution in light of the expanding use of this «steroid sparing» agent. Arch Intern Med 1990; 150: 889-91.
8. WEST SG. Methotrexate hepatotoxicity. Rheum Dis Clin North Am 1997; 23: 883-915.
9. STRICKER BH, BLOK AP, CLAAS FH, VANPARYS GE, DESMET VT. Hepatic injury associated with the use of nitrofurantoin: A clinicopathological study of 52 reported cases. Hepatology 1988; 8: 599-606.
10. HATOFF DE, COHEN M, SCHWEIGERT BF, TALBERT WM. Nitrofurantoin: Another cause of drug-induced chronic active hepatitis? Am J Med 1979; 67: 117-21.
11. GRONHAGEN-RISKA C, HELLSTROM PE, FROSE THB. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Am Rev Respir Dis 1978; 118: 461-6.
12. GRADON JD, CHAPNICK EK, SEPKOWITS DV. Zidovudine-induced hepatitis. J Intern Med 1992; 231: 317-8.
13. SCHIANO TD, LISSOS TW, AHMED A, SIANO C, ZAITMAN D, COHN G ET AL. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis. Am J Gastroenterol 1997; 92: 1563-4.
14. PONIACHIK J, GUERRERO J, CALDERON P, SMOK G, MORALES A, MUÑOZ G ET AL. Hepatitis colestásica por piroxicam: caso clínico. Rev Méd Chile 1998; 126: 548-52.
15. HELFGOTT SM, SANDBERG-COOK J, ZAKIM D, NESTLER J. Diclofenac-associated hepatotoxicity. JAMA 1990; 264: 2660-2.
16. SOE K, SOE M, GLUUD C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 1992; 12: 73-9.
17. BROWN BR, GANDOLF AJ. Adverse effects of volatile anaesthetics. Br J Anaesth 1987; 59: 14-23.
18. NEUBERGER J. Halothane hepatitis. Eur J Gastroenterol Hepatol 1998; 10: 631-3.
19. LIAW Y, HUANG M, FAN K, WU SS, CHEN TJ. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism: A cohort study. Ann Intern Med 1993; 118: 424-8.
20. SAFANI MM, TATRO DS, RUDD P. Fatal propylthiouracil-induced hepatitis. Arch Intern Med 1982; 142: 838-9.